Acute Market Reports, Asthma – Pipeline Review, H1 2016, provides an overview of the Asthma pipeline landscape.
The report provides comprehensive information on the therapeutics under development for Asthma, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an overview of key players involved in therapeutic development for Asthma and features dormant and discontinued projects.
Browse Full Report Visit – http://www.acutemarketreports.com/report/asthma-pipeline-review-h1-2016
Acute Market Reports report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Acute Market Reports proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Drug profiles featured in the report undergoes periodic review following a stringent set of processes to ensure that all the profiles are updated with the latest set of information. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.
The report helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage.
Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data.
Scope
– The report provides a snapshot of the global therapeutic landscape of Asthma
– The report reviews pipeline therapeutics for Asthma by companies and universities/research institutes based on information derived from company and industry-specific sources
– The report covers pipeline products based on various stages of development ranging from pre-registration till discovery and undisclosed stages
– The report features descriptive drug profiles for the pipeline products which includes, product description, descriptive MoA, R&D brief, licensing and collaboration details & other developmental activities
– The report reviews key players involved Asthma therapeutics and enlists all their major and minor projects
– The report assesses Asthma therapeutics based on drug target, mechanism of action (MoA), route of administration (RoA) and molecule type
– The report summarizes all the dormant and discontinued pipeline projects
– The report reviews latest news related to pipeline therapeutics for Asthma
Browse All Reports of This Category – http://www.acutemarketreports.com/category/healthcare-market
Reasons to buy
– Gain strategically significant competitor information, analysis, and insights to formulate effective R&D strategies
– Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
– Identify and understand important and diverse types of therapeutics under development for Asthma
– Identify potential new clients or partners in the target demographic
– Develop strategic initiatives by understanding the focus areas of leading companies
– Plan mergers and acquisitions effectively by identifying key players and its most promising pipeline therapeutics
– Devise corrective measures for pipeline projects by understanding Asthma pipeline depth and focus of Indication therapeutics
– Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
– Modify the therapeutic portfolio by identifying discontinued projects and understanding the factors that drove them from pipeline
Table of Contents 2
Introduction 9
Asthma Overview 10
Therapeutics Development 11
Asthma – Therapeutics under Development by Companies 13
Asthma – Therapeutics under Investigation by Universities/Institutes 25
Asthma – Pipeline Products Glance 27
Asthma – Products under Development by Companies 31
Asthma – Products under Investigation by Universities/Institutes 49
Asthma – Companies Involved in Therapeutics Development 51
Asthma – Therapeutics Assessment 180
Drug Profiles 216
Asthma – Recent Pipeline Updates 587
Asthma – Dormant Projects 689
Asthma – Discontinued Products 723
Asthma – Product Development Milestones 732
Appendix 741
Purchase a Copy Of This Report – http://www.acutemarketreports.com/request-free-sample/74166
Number of Products under Development for Asthma, H1 2016 41
Number of Products under Development for Asthma – Comparative Analysis, H1 2016 42
Number of Products under Development by Companies, H1 2016 44
Number of Products under Development by Companies, H1 2016 (Contd..1) 45
Number of Products under Development by Companies, H1 2016 (Contd..2) 46
Number of Products under Development by Companies, H1 2016 (Contd..3) 47
Number of Products under Development by Companies, H1 2016 (Contd..4) 48
Number of Products under Development by Companies, H1 2016 (Contd..5) 49
Number of Products under Development by Companies, H1 2016 (Contd..6) 50
Number of Products under Development by Companies, H1 2016 (Contd..7) 51
Number of Products under Development by Companies, H1 2016 (Contd..8) 52
Number of Products under Development by Companies, H1 2016 (Contd..9) 53
Number of Products under Development by Companies, H1 2016 (Contd..10) 54
Number of Products under Investigation by Universities/Institutes, H1 2016 56
Comparative Analysis by Late Stage Development, H1 2016 57
Comparative Analysis by Clinical Stage Development, H1 2016 58
Comparative Analysis by Early Stage Development, H1 2016 59
Comparative Analysis by Unknown Stage Development, H1 2016 60
Products under Development by Companies, H1 2016 61
Products under Development by Companies, H1 2016 (Contd..1) 62
Products under Development by Companies, H1 2016 (Contd..2) 63
Products under Development by Companies, H1 2016 (Contd..3) 64
Products under Development by Companies, H1 2016 (Contd..4) 65
Products under Development by Companies, H1 2016 (Contd..5) 66
Products under Development by Companies, H1 2016 (Contd..6) 67
Products under Development by Companies, H1 2016 (Contd..7) 68
Products under Development by Companies, H1 2016 (Contd..8) 69
Products under Development by Companies, H1 2016 (Contd..9) 70
Products under Development by Companies, H1 2016 (Contd..10) 71
Products under Development by Companies, H1 2016 (Contd..11) 72
Products under Development by Companies, H1 2016 (Contd..12) 73
Products under Development by Companies, H1 2016 (Contd..13) 74
Products under Development by Companies, H1 2016 (Contd..14) 75
Products under Development by Companies, H1 2016 (Contd..15) 76
Products under Development by Companies, H1 2016 (Contd..16) 77
Products under Development by Companies, H1 2016 (Contd..17) 78
Products under Investigation by Universities/Institutes, H1 2016 79
Products under Investigation by Universities/Institutes, H1 2016 (Contd..1) 80
Asthma – Pipeline by 4D Pharma Plc, H1 2016 81
Asthma – Pipeline by AB Science SA, H1 2016 82
Asthma – Pipeline by Abeome Corporation, H1 2016 83
Asthma – Pipeline by Accolade Pharmaceuticals, LLC, H1 2016 84
Asthma – Pipeline by Acorda Therapeutics, Inc., H1 2016 85
Asthma – Pipeline by Adamis Pharmaceuticals Corporation, H1 2016 86
Asthma – Pipeline by Advinus Therapeutics Ltd., H1 2016 87
Asthma – Pipeline by Afferent Pharmaceuticals, Inc., H1 2016 88
Asthma – Pipeline by ALK-Abello A/S, H1 2016 89
Asthma – Pipeline by Allergopharma GmbH & Co. KG, H1 2016 90
Asthma – Pipeline by Almirall, S.A., H1 2016 91
Asthma – Pipeline by Amakem NV, H1 2016 92
Asthma – Pipeline by Amgen Inc., H1 2016 93
Asthma – Pipeline by AnaptysBio, Inc., H1 2016 94
Asthma – Pipeline by Antisense Therapeutics Limited, H1 2016 95
Asthma – Pipeline by Aquinox Pharmaceuticals Inc., H1 2016 96
Asthma – Pipeline by ARA Healthcare Pvt. Ltd., H1 2016 97
Asthma – Pipeline by Ario Pharma Ltd, H1 2016 98
Asthma – Pipeline by ASIT biotech s.a., H1 2016 99
Asthma – Pipeline by Aslan Pharmaceuticals Pte. Ltd., H1 2016 100
Asthma – Pipeline by Astellas Pharma Inc., H1 2016 101
Asthma – Pipeline by AstraZeneca Plc, H1 2016 102
Asthma – Pipeline by Asubio Pharma Co., Ltd., H1 2016 103
Asthma – Pipeline by Aurigene Discovery Technologies Limited, H1 2016 104
Asthma – Pipeline by Axikin Pharmaceuticals, Inc., H1 2016 105
Asthma – Pipeline by Baxalta Incorporated, H1 2016 106
Asthma – Pipeline by Bioncotech Therapeutics S.L., H1 2016 107
Asthma – Pipeline by Biotec Pharmacon ASA, H1 2016 108
Asthma – Pipeline by Boehringer Ingelheim GmbH, H1 2016 109
Asthma – Pipeline by Caladrius Biosciences, Inc. , H1 2016 110
Asthma – Pipeline by CalciMedica, Inc., H1 2016 111
Asthma – Pipeline by Carolus Therapeutics, Inc., H1 2016 112
For Technology News : http://www.mobilecomputingtoday.co.uk/
About – Acute Market Reports :
Acute Market Reports is the most sufficient collection of market intelligence services online. It is your only source that can fulfill all your market research requirements.We provide online reports from over 100 best publishers and upgrade our collection regularly to offer you direct online access to the world’s most comprehensive and recent database with expert perceptions on worldwide industries, products, establishments and trends.
Our team consists of highly motivated market research professionals and they are accountable for creating the groundbreaking technology that we utilize in our search engine operations to easily recognize the most current market research reports online.
Contact Us :
Chris Paul
ACUTE MARKET REPORTS
Office No 101, 1st Floor ,
Aditi Mall, Baner,
Pune, MH, 411045
India
Toll Free(US/CANADA): +1-855-455-8662
India: +91 7755981103
Email : sales@acutemarketreports.com
Website : http://www.acutemarketreports.com